Do GLP-1 Patches Work? What’s in Them and What Studies Show
Do GLP-1 patches work? What experts say is in them, why GLP-1 drugs are too large to pass through skin, and what berberine and GLP-1 drug trials report.
By Juan Montes
Updated October 19, 2026 · 7 min read
Disclosure: PrescribedRX sells its own treatments, so we compete with some of the companies covered here, and we may earn affiliate commissions. PrescribedRX is a telehealth platform; prescriptions are written by licensed clinicians and filled by licensed partner pharmacies.
Short answer: GLP-1 patches are adhesive patches sold without a prescription. Experts quoted by TODAY and Cleveland Clinic describe the patches sold online as mostly herbal blends such as berberine, green tea extract and cinnamon rather than semaglutide or tirzepatide. An endocrinologist told Cleveland Clinic there is no scientific evidence the body can effectively absorb berberine through the skin. The GLP-1 medicines with published trial data are prescription drugs such as semaglutide and tirzepatide.
What is a GLP-1 patch?
A “GLP-1 patch” is an adhesive patch sold without a prescription, usually through social media ads, with “GLP-1” in its name. GLP-1 is a gut hormone. Prescription drugs such as semaglutide (Wegovy) and tirzepatide (Zepbound) act on GLP-1 receptors and are injected once a week (Wegovy prescribing information; Zepbound prescribing information).
The simplest test is the prescription. Jamie Alan, an associate professor of pharmacology and toxicology at Michigan State University, told NBC News that a product you can buy without a prescription is not an actual GLP-1 drug (as reported by TODAY).
What’s actually in GLP-1 patches?
According to C. Michael White of the University of Connecticut, berberine is usually the main ingredient. Other common ingredients include green tea extract (EGCG), garcinia cambogia, pomegranate extract, mango seed extract, ginger root extract, cinnamon, L-glutamine and assorted vitamins and minerals (TODAY). Cleveland Clinic lists a similar mix, including caffeine (Cleveland Clinic).
You also can’t be sure the label is right. Endocrinologist Keren Zhou, MD, told Cleveland Clinic there is no reliable way to confirm what a patch contains or how much of each ingredient is in it, and that makers may add unlisted ingredients or leave out listed ones (Cleveland Clinic).
Do any GLP-1 patches contain real GLP-1 drugs?
Not according to the experts quoted by TODAY, who describe the patches sold online as herbal blends rather than GLP-1 drugs (TODAY).
Real research does exist. A Phase 1 trial is testing VX-201, a semaglutide microarray patch from Terrestrial Bio, against standard injections. It started recruiting on June 15, 2026, with primary completion estimated for February 2027 (ClinicalTrials.gov NCT07673900). Phase 1 tests safety, not weight loss, and the device is not for sale.
Why can’t a patch deliver a GLP-1 through the skin?
Size is the main problem. In a widely cited paper, dermatologists Bos and Meinardi described the “500 Dalton rule”: a compound generally needs a molecular weight under about 500 Daltons to pass through the skin, and every common transdermal drug at the time was under that limit (Bos and Meinardi, 2000).
GLP-1 drugs are far larger. Semaglutide has a molecular weight of 4,113.58 g/mol (Wegovy prescribing information) and tirzepatide is 4,813.53 Da (Zepbound prescribing information). That is roughly 8 to 10 times the limit.
| Molecule | Approximate size (Daltons) | Compared with the 500 Da skin limit |
|---|---|---|
| Berberine | 336.4 | Under the limit |
| Skin limit (rule of thumb) | 500 | Threshold |
| Semaglutide | 4,113.58 | About 8 times over |
| Tirzepatide | 4,813.53 | About 10 times over |
Berberine is small at 336.4 Da (PubChem), so size alone does not rule it out. But Dr. Zhou says there is no scientific evidence the body can effectively absorb berberine through the skin, and no proof that berberine from a patch reaches the bloodstream in a way that affects weight (Cleveland Clinic).
Does berberine work for weight loss?
The evidence is limited, and it covers swallowed berberine. A January 2026 meta-analysis of randomized trials reported that people taking berberine lost an average of 0.88 kg (about 2 pounds) more than control groups, with BMI down 0.48 kg/m2, and the authors flagged weak blinding and poor reporting of product purity (Int J Obes, 2026). Those were oral doses. White told TODAY these ingredients have not been studied for going through the skin at all (TODAY).
What does the FTC say about weight loss patches?
The FTC’s guide for spotting false weight loss claims, published in January 2014, says: “Nothing you wear or apply to the skin can cause substantial weight loss” (FTC Gut Check).
Why do GLP-1 patch reviews look so positive?
Anyone can post a review, and White told TODAY that the ingredients have not been studied for absorption through the skin. Dr. Melanie Jay of NYU told TODAY there could be a placebo effect (TODAY).
Reviews also report problems. White and his students found online reviews describing skin rashes, burns and blisters, and he could not tell whether undisclosed latex or ingredients such as mango, ginger, cinnamon or berberine were to blame (TODAY). Cleveland Clinic adds that the adhesive itself can cause contact dermatitis (Cleveland Clinic).
GLP-1 patch claims vs the evidence
| What the ads claim | What the sources say | Source |
|---|---|---|
| “Works like Ozempic” or “GLP-1” | Experts quoted by TODAY and Cleveland Clinic describe herbal ingredients, not GLP-1 drugs | TODAY, Cleveland Clinic |
| “Delivers GLP-1 through the skin” | GLP-1 drugs are about 4,100 to 4,800 Da; the 500 Dalton rule says compounds generally need to be under about 500 Da to pass through skin | Bos and Meinardi, Wegovy and Zepbound prescribing information |
| “Berberine is nature’s Ozempic” | Swallowed berberine: 0.88 kg average loss in a 2026 meta-analysis; no human data for patches | Int J Obes 2026, Cleveland Clinic |
| “Clinically proven” | The semaglutide patch trial listed on ClinicalTrials.gov is a Phase 1 safety study of a microarray device that is not sold to consumers | NCT07673900 |
| “Melts fat while you wear it” | The FTC says nothing worn or applied to the skin can cause substantial weight loss | FTC Gut Check |
| “Thousands of 5-star reviews” | Anyone can post a review; an NYU doctor told TODAY there could be a placebo effect; some reviews describe rashes, burns and blisters | TODAY |
What do trials of prescription GLP-1 medicines report?
The GLP-1 medicines with published trial results are prescription drugs. Their prescribing information reports:
- Wegovy (semaglutide) injection. In the 68-week STEP 1 trial, people on semaglutide 2.4 mg lost 14.9% of body weight on average, compared with 2.4% on placebo (Wegovy prescribing information).
- Zepbound (tirzepatide) injection. In the 72-week SURMOUNT-1 trial, average weight loss was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg, compared with 3.1% on placebo (Zepbound prescribing information).
These results are trial averages for the branded drugs. They are not a promise for any one person, and they do not automatically apply to compounded versions.
PrescribedRX offers compounded semaglutide and compounded tirzepatide. Compounded medications are prepared by licensed pharmacies and are not FDA-approved, and they are not the same as Wegovy or Zepbound. A licensed provider decides whether it is appropriate for you, and your provider sets the dose. Our guide to who qualifies for a GLP-1 explains the intake questions.
How do PrescribedRX GLP-1 plans work, and what do they cost?
You answer a short online eligibility check. A licensed provider reviews every intake, typically within 48 hours, and a licensed provider decides whether it is appropriate for you. Prescriptions are written by state-licensed clinicians through Telegra MD and filled by licensed partner pharmacies, with free priority shipping. Plans are self-pay with no insurance, and availability varies by state. Prices as shown on prescribedrx.com in October 2026:
| Plan | Price as shown on the site | Type |
|---|---|---|
| Compounded semaglutide | 3 month plan $420 · $140/mo · Billed every 3 months. Cancel anytime. | Compounded |
| Compounded tirzepatide | 3 month plan $597 · $199/mo · Billed every 3 months. Cancel anytime. | Compounded |
Same price at every dose. Compare them in compounded semaglutide vs tirzepatide, or see what tirzepatide costs across providers.
When should you talk to a doctor?
If you are using a patch and have a skin reaction or other symptoms, talk to a licensed provider. Cleveland Clinic notes the adhesive itself can cause contact dermatitis (Cleveland Clinic).
If you are on a prescription GLP-1, talk with your provider about any side effects. For general education, see semaglutide side effects and the tirzepatide side effect list.
GLP-1 patch FAQ
Do GLP-1 patches contain semaglutide or tirzepatide?
Not according to experts quoted by TODAY and Cleveland Clinic, who describe herbal blends such as berberine, green tea extract and cinnamon. The only semaglutide patch listed on ClinicalTrials.gov is a Phase 1 microarray device that is not for sale.
Looking for a prescription GLP-1?
Take the 2-minute eligibility quiz. A licensed provider decides whether it is appropriate for you. Compounded semaglutide: 3 month plan $420 · $140/mo · Billed every 3 months. Cancel anytime. Take the eligibility quiz or explore compounded semaglutide and tirzepatide plans.
Related reading: GLP-1 supplements: what the evidence reports
Sources
- Federal Trade Commission. Gut Check: A Reference Guide for Media on Spotting False Weight Loss Claims, January 2014. ftc.gov. Accessed Oct 2026.
- Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000. PubMed. Accessed Oct 2026.
- DailyMed. Wegovy (semaglutide) prescribing information. National Library of Medicine, NIH. dailymed.nlm.nih.gov. Accessed Oct 2026.
- DailyMed. Zepbound (tirzepatide) prescribing information. National Library of Medicine, NIH. dailymed.nlm.nih.gov. Accessed Oct 2026.
- The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes. January 2026. PubMed. Accessed Oct 2026.
- ClinicalTrials.gov. Semaglutide by Microarray Patch (VX-201) vs Subcutaneous, NCT07673900. clinicaltrials.gov. Accessed Oct 2026.
- Pawlowski A. Do “GLP-1 Patches” Work for Weight Loss? Doctors Warn About Trend. TODAY, September 19, 2025. today.com. Accessed Oct 2026.
- Cleveland Clinic. Do GLP-1 Patches Actually Work? September 17, 2026. health.clevelandclinic.org. Accessed Oct 2026.
- PubChem. Berberine (CID 2353). National Library of Medicine, NIH. pubchem.ncbi.nlm.nih.gov. Accessed Oct 2026.
This article is for general information. It is not medical advice and it is not a recommendation for any particular treatment. Whether a treatment is appropriate for you is a decision for a licensed clinician who has reviewed your health history and current medications.
About the author
Juan MontesJuan Montes writes and reviews PrescribedRX's clinical content, covering testosterone replacement therapy, men's sexual health, weight management and hair loss. He trained as a Professional Nurse at the Colombian Red Cross in Cali, Colombia, and has worked in healthcare since 2011, roughly six of those years in direct emergency and critical care nursing. He served as Head Nurse in Emergency…
More from Juan →This article is for information only and is not medical advice. Treatment is prescribed solely at the discretion of a licensed provider following a clinical evaluation.
